Crohn's disease and Malabsorption

Summary:

Malabsorption is found among people with Crohn's disease, especially for people who are female, 50-59 old.

The study analyzes which people have Malabsorption with Crohn's disease. It is created by eHealthMe based on reports of 330 people who have Crohn's disease from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Crohn's disease?

Crohn's disease (a condition that causes inflammation of the gastrointestinal tract) is found to be associated with 1,350 drugs and 2,077 conditions by eHealthMe. Check the latest studies of Crohn's disease.

What is Malabsorption?

Malabsorption (a state arising from abnormality in absorption of food nutrients across the gastrointestinal (gi) tract) is found to be associated with 633 drugs and 1,101 conditions by eHealthMe. Check the latest studies of Malabsorption.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 25, 2026

330 people who have Crohn'S Disease and Malabsorption are studied.

Would you have Malabsorption when you have Crohn's disease?

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Malabsorption?

- Check whether Malabsorption is associated with a drug or a condition

Related studies:

Treatments, associated drugs and conditions:

Crohn's disease (390,234 reports)
Malabsorption (8,910 reports)

All the drugs that are associated with Malabsorption:

Malabsorption (633 drugs)

All the conditions that are associated with Malabsorption:

Malabsorption (1,101 conditions)

How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Malabsorption and Crohn's disease, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.